Pharmaceutical strategy & execution advisory
India · UK · InternationalWhere pharmaceutical ambition becomes executable strategy.
We advise pharmaceutical leaders on growth, portfolio, product development, technology transfer, market entry, commercial readiness, supply resilience, and digital operating models.
The work begins with a decision
Questions that change the direction of the business.
Leading advisory firms organise around the client's hardest decisions—not around a catalogue of services. That is now the organising principle of NIT.
Which products and markets deserve capital now?
How should we enter without overbuilding the organisation?
Which partner can execute—not merely promise?
Where will development or transfer fail before it becomes visible?
How do we build resilience without creating waste?
What should data and AI actually change in the operating model?
Our expertise
Specialist pharma depth. Integrated business judgement.
We connect strategy, science, manufacturing, markets, partners, operations, and technology—because pharmaceutical decisions rarely fail in only one function.
View all expertise01
Strategy & growth
Choose where to play—and what it will take to win.
We help leadership teams turn broad growth ambition into a focused set of choices across markets, categories, channels, capabilities, and investment priorities.
Questions we help answer
- Which growth spaces are strategically attractive and operationally credible?
- What should be built, acquired, licensed, partnered, or exited?
- Which assumptions matter most to the investment case?
Typical outputs
- Growth thesis and strategic choices
- Opportunity prioritisation
- Scenario and risk architecture
- Execution roadmap and governance
An end-to-end decision horizon
From product thesis to market performance.
Our perspective follows the full chain of value. We identify where a decision made today creates an advantage—or a hidden constraint—several stages later.
- 01Opportunity
- 02Portfolio
- 03Development
- 04Transfer
- 05Access
- 06Launch
- 07Scale
Perspective
India intelligence.
International perspective.
We work at the intersection of Indian pharmaceutical capability and international market expectations.
That perspective is valuable where development, manufacturing, licensing, distribution, quality, commercial, and market-entry choices must work across different operating realities. We translate between them without reducing either side to a stereotype.
About NITSectors
Built for the businesses shaping access to health.
Pharmaceuticals & generics
Portfolio choices, development pathways, international market entry, product acquisition, commercial readiness, and resilient supply models for established and growth-stage pharmaceutical businesses.
02Biotech & specialty pharma
Decision support for focused portfolios, external innovation, partner strategy, asset positioning, development planning, and commercial pathway design where capital and specialist capability must be tightly allocated.
03Consumer health & nutraceuticals
Category, portfolio, evidence, formulation, channel, brand, distribution, and international market-entry strategy for science-led consumer health businesses.
04Medical devices & diagnostics
Product-market fit, partner selection, market-entry model, evidence and regulatory dependency mapping, launch readiness, and commercial pathway planning.
05Manufacturers & CDMOs
Growth strategy, capability positioning, target-market alignment, customer proposition, technology-transfer readiness, programme governance, and partnership development for manufacturing organisations.
06Distributors & market-access organisations
Portfolio strategy, supplier architecture, channel model, differentiated proposition, account strategy, data visibility, and operating resilience for organisations connecting products to markets.
Current thinking
Ideas designed to improve the next decision.
We do not sell certainty.
We make uncertainty decision-ready.
The purpose of advisory work is not to make a complicated situation sound simple. It is to make the choices, evidence, trade-offs, responsibilities, and path to action clear enough to move with conviction.
How we work